Table 3.
G8 score and other measures of GA.
| All patients (n = 207), n(%) | With CT (n= 143), n(%) | Without CT (n = 64), n(%) | P-value* | ||
|---|---|---|---|---|---|
| G8 score | Median (range) | 10.5 (2–16) | 11.5 (6–16) | 10 (2–16) | <0.0001 |
| Normal | 15 (6.8) | 14 (9.8) | 1 (1.6) | 0.041 | |
| Abnormal | 192 (93.2) | 129 (90.2) | 63 (98.4) | ||
| IADL | Normal | 107 (51.7) | 92 (64.3) | 15 (23.4) | <0.0001 |
| Abnormal | 81 (39.1) | 37 (25.9) | 44 (68.8) | ||
| Unknown | 19 (9.2) | 14 (9.8) | 5 (7.8) | ||
| Living situation | With others together | 163 (78.7) | 111 (77.6) | 52 (81.3) | 0.068 |
| Alone at home | 42 (20.3) | 32 (22.4) | 10 (15.6) | ||
| Nursing home | 2 (1.0) | 0 (0.0) | 2 (3.1) |
G8, geriatric 8; GA, geriatric assessment; IADL, instrumental activities of daily living; CT, chemotherapy.
*Difference in G8 score between patients with or without chemotherapy was analyzed by the Wilcoxon test. Differences in IADL or living situation between patients with and without chemotherapy were determined by Fisher’s exact test.